Summary
Overview
Work History
Education
Skills
Timeline
Generic

Minas Mikros

Roselle Park

Summary

Mass spectrometry technologist specializing in delivering accurate client drug identification and analysis through advanced processing in adherence to D.O.T regulations.

Overview

7
7
years of professional experience

Work History

Mass Spectrometry Technologist - Forensic Toxicology

Labcorp
Raritan, NJ
10.2023 - Current
  • Perform analysis of patient/client drug samples using LCMS & GCMS confirmation testing, in addition to PT and ODT specimens, to produce accurate results.
  • Adept in LIMS and LCTS software to inquire, process, maintain chain of custody and release accurate sample drug results for further review to clients.
  • Certified in reviewing federally regulated D.O.T batches in compliance with federal regulations using a stricter analysis, integration and quality control standards.
  • Compliance with strict S.O.P and GxP protocols within a heavily regulated laboratory environment.
  • Full transparency on laboratory standards adhering to regulations and inspections by NLCP, CLIA, CAP and the New York State Dept. of Health Inspectors.
  • Collaboration with other departments to identify issues with samples and quality control (QC) specimens, preventing inaccurate drug batch runs, reducing turnaround time and operational costs.
  • Perform consistent instrument maintenance by observing calibration curves and QC trends from the beginning to prevent continued delays and prevent third party maintenance, saving company money.
  • Maintenance of audit available documentation and compliance with chain of custody for inspection to support complete transparency and operational integrity.

Neurodegenerative Disease Independent Research Stream

Kean University
Union, NJ
09.2022 - 05.2023
  • Identified pathways to introduce CD33 mutated and wild type constructs into Flp-In cell lines to optimize transfection and cell culture conditions to achieve stable and viable cells.
  • Integrated findings and formulated thesis research paper, to identify the role of CD33 mutations in Alzheimer’s.

Pharmaceutical Compatibility Internship

Sanguine Biosciences
Waltham, MA
09.2021 - 12.2021
  • Conducted extensive research on pharmaceutical and biotechnology companies’ pipeline to determine strategic partnerships and compatibility to better connect clinical stage research trials with corresponding patients.
  • Determined therapeutic areas of focus in alignment with research goals and presented findings to create a path for future directions of research and clinical applications.

COVID-19 Genetics Independent Research Student

Kean University
Union, NJ
01.2021 - 12.2021
  • Conducted research on genetic sequences of SARS-CoV-2 strains, utilizing bioinformatics tools such as Galaxy ARIES to determine amino acid/nucleotide variations and identify patterns of mutations.
  • Determined functional differences from protein structures corresponding to amino acid variations to identify function of viral entry and rate of transmissibility COVID-19.
  • Constructed phylogenetic tree to determine relationship amongst viral strains to have a more complete understanding of the viral evolution of COVID-19.

Synthesis of Eph Receptor Legacy Inhibitor Independent Research

Kean University
Union, NJ
01.2020 - 12.2020
  • Initiated the synthesis of a known Eph receptor kinase inhibitor to analyse its hypothesized role in the signalling pathways of glioblastoma.
  • Refined precursor compounds using NMR and TLC to verify structural purity and integrity & integrated laboratory finding with complementary literature to guide research strategy and better understand the relationship between inhibitor and cancer pathways.

CCRI Antagonists Advanced Research Student

Kean University
Union, NJ
01.2019 - 12.2019
  • Synthesized CCR1 antagonists that target chemokine mediated inflammatory pathways involved in the proliferation of immune cells progression of cancer.
  • Compared experimental findings with peer reviewed literature research and presented findings on the mechanisms of CCR1 antagonist compounds to discuss potential oncological therapeutic pathways.

Education

Masters of Science - Molecular Biology

Kean University
Union, NJ
05.2023

Bachelors of Science - Biotechnology

Kean University
Union, NJ
05.2022

Skills

  • Molecular Biology
  • DNA and amino acid sequencing (BLAST)
  • ELISA flow cytometry
  • SDS-PAGE electrophoresis
  • Mammalian cell culture
  • RAW2647 & Flp-In293 cell line
  • Microbiology
  • Bacterial cultivation using selective and differential media
  • Bacterial staining, streaking, plating and aseptic techniques
  • Analytical Chemistry
  • LCMS/GCMS operator, data analysis
  • Infrared spectroscopy (IR) and nuclear magnetic resonance (NMR)
  • Thin layer chromatography (TLC), rotary evaporation, Buchner filtration and distillation
  • Computer & Software
  • Word Processing
  • Word, Excel, Powerpoint
  • Programming
  • JAVA, R Studio, MATLAB
  • DNA Sequencing
  • Galaxy ARIES

Timeline

Mass Spectrometry Technologist - Forensic Toxicology

Labcorp
10.2023 - Current

Neurodegenerative Disease Independent Research Stream

Kean University
09.2022 - 05.2023

Pharmaceutical Compatibility Internship

Sanguine Biosciences
09.2021 - 12.2021

COVID-19 Genetics Independent Research Student

Kean University
01.2021 - 12.2021

Synthesis of Eph Receptor Legacy Inhibitor Independent Research

Kean University
01.2020 - 12.2020

CCRI Antagonists Advanced Research Student

Kean University
01.2019 - 12.2019

Bachelors of Science - Biotechnology

Kean University

Masters of Science - Molecular Biology

Kean University